Clinical Trial Update: Subcutaneous Elafin in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating subcutaneous elafin in healthy subjects has completed, focusing on safety and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Elafin (elafin)

Snippet

Sponsor: Roham T. Zamanian | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: COMPLETED